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A single exposure to drugs of abuse produces an
NMDA receptor (NMDAR)-dependent long-term
potentiation (LTP) of AMPA receptor (AMPAR) cur-
rents in DA neurons; however, the importance of
LTP for various aspects of drug addiction is unclear.
To test the role of NMDAR-dependent plasticity in
addictive behavior, we genetically inactivated func-
tional NMDAR signaling exclusively in DA neurons
(KO mice). Inactivation of NMDARs results in in-
creased AMPAR-mediated transmission that is in-
distinguishable from the increases associated with
a single cocaine exposure, yet locomotor responses
to multiple drugs of abuse were unaltered in the KO
mice. The initial phase of locomotor sensitization to
cocaine is intact; however, the delayed sensitization
that occurs with prolonged cocaine withdrawal did
not occur. Conditioned behavioral responses for
cocaine-testing environment were also absent in
the KO mice. These findings provide evidence for
a role of NMDAR signaling in DA neurons for specific
behavioral modifications associated with drug seek-
ing behaviors.
INTRODUCTION
The mesolimbic DA circuit, consisting of midbrain DA neurons in
the ventral tegmental area (VTA), that project to the nucleus ac-
cumbens (NAc) and prefrontal cortex, plays a key role in reward
and motivation and is a major target of abused drugs (Wise,
2004). Repeated exposure to drugs of abuse increases their psy-
chomotor stimulant effects and elicits conditioned preferences
for neutral stimuli in animal models of addiction. These behaviors
are thought to reflect increased incentive motivation for drug ac-
quisition and contextual or cue-evoked, drug-seeking behavior
(Robinson and Berridge, 1993). Two classical models used to
study these correlates of addiction are locomotor (or behavioral)
sensitization and conditioned place preference (CPP) (Etten-
berg, 1989; Kalivas and Stewart, 1991). The acquisition and ex-
pression of locomotor sensitization and CPP are attenuated by
glutamate receptor antagonists, strongly implicating glutamate
signaling and synaptic plasticity in the mesolimbic DA circuit
as an underlying mechanism in addiction.486 Neuron 59, 486–496, August 14, 2008 ª2008 Elsevier Inc.Plasticity at excitatory glutamatergic synapses plays a critical
role in memory acquisition and consolidation. Signal trans-
duction cascades, initiated by Ca2+ influx through NMDARs,
mediate a rapid and sustained enhancement of glutamatergic
synapses by regulating local synaptic strength through the mod-
ulation of AMPAR number and function (Malinow and Malenka,
2002). Drugs of abuse evoke an NMDAR-dependent, long-term
potentiation (LTP) of AMPAR currents in DA neurons that may re-
flect an earlymemory trace in the acquisition of drug dependence
(Borgland et al., 2004; Liu et al., 2005; Saal et al., 2003; Ungless
et al., 2001). Functionally, LTP of AMPARcurrents in VTADAneu-
rons following drug exposure is coincidentwith increasedAMPA-
evokedDA release that is thought to underlie the initiation of drug
sensitization (Dunn et al., 2005; Kalivas and Alesdatter, 1993;
Vezina and Queen, 2000; Zhang et al., 1997).
A dichotomy currently exists regarding the role of glutamate
plasticitywithinVTADAneuronsasacritical neural adaptationun-
derlying drug-seeking behavior (Tzschentke and Schmidt, 2000;
VanderschurenandKalivas,2000).Site-specific injectionofgluta-
mate antagonists into the VTA during repeated drug administra-
tion blocked behavioral sensitization (Dunn et al., 2005; Kalivas
and Alesdatter, 1993; Vezina and Queen, 2000) and attenuated
CPP (Harris andAston-Jones, 2003; Harris et al., 2004). However,
repeated infusion of NMDA directly into the VTA did not induce
a sensitized response to a systemic cocaine injection (Schenk
and Partridge, 1997). In addition, other groups have demon-
stratedday-to-day increases in locomotor responding toamphet-
amine or morphine when NMDAR antagonists were present dur-
ing testing (Ranaldi et al., 2000). Disparities regarding the role of
AMPARs also exist. Viral overexpression of the AMPAR subunit
GluR1 produced a sensitized behavioral response to acute mor-
phine treatment (Carlezonet al., 1997), and infusionofAMPARan-
tagonists into the VTA prevented sensitization (Dunn et al., 2005).
However, mice with a genetic deletion of the AMPAR subunit
GluR1 lacked cocaine-induced plasticity in DA neurons, yet be-
havioral sensitization was normal (Dong et al., 2004).
Significant differences in the methodologies used in these
studies could explain the discrepancies observed, but they all
share a lack of cell specificity. Although NMDAR antagonists
were injected directly into the VTA, other cell types in this brain
region likely express these receptors, such as GABAergic inter-
neurons, GABAergic projection (Korotkova et al., 2004; Olson
and Nestler, 2007), and glutamatergic neurons (Yamaguchi
et al., 2007). Similarly, viral-mediated delivery of GluR1 likely in-
fected both DA and non-DA neurons within the VTA, and the
GluR1 knockout mice lacked this subunit in all cells.
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ing in DA neurons for the long-term changes associated with
drug exposure, we selectively inactivated NMDAR signaling in
these cells. Absence of functional NMDAR increased synaptic
AMPAR currents in DA neurons that were similar to the changes
associated with a single cocaine exposure in vivo. Acute re-
sponses to the locomotor-stimulating effects of cocaine and
other drugs of abuse were unaltered in mice lacking functional
NMDAR in DA neurons, and the induction of behavioral sensitiza-
tion progressed normally; however, cue-evoked drug seeking
and the enhancement of drug craving following withdrawal
were significantly impaired.
RESULTS
Selective Inactivation of NMDARs in DA Neurons
NMDARs are heteromeric ion channels that are critically depen-
dent on the NR1 subunit for proper channel function. Cell-spe-
cific, conditional inactivation of the NR1 subunit prevents
NMDAR-mediated currents, blocks the induction of LTP, and
impairs some forms of learning and memory (Tsien et al., 1996).
To determine if NMDAR-dependent plasticity in DA neurons is
critical for the neural adaptations associated with repeated
drug administration, we used a genetic approach to selectively
inactivate the NR1 subunit of the NMDARs in DA neurons. Cell-
specific inactivation of the floxed NR1 (Grin1lox) allele (Tsien
et al., 1996) was achieved by crossing these mice with mice ex-
pressing Cre recombinase under the control of the endogenous
DA transporter gene (Slc6a3Cre) (Zhuang et al., 2005). For the ex-
periments described here, Slc6a3+/Cre;Grin1D/lox (knockout, KO)
mice and Slc6a3+/Cre; Grin1+/lox (control) mice were used
(Figure 1A). Both KO and control mice have one functional allele
for the DA transporter and one functional allele of NR1, except in
DA neurons where Cre-mediated recombination should inacti-
vate the remaining Grin1lox allele. KO mice were born at the
expected Mendelian ratio and were visibly indistinguishable
from control mice.
To confirm that Cre-mediated recombination in Sl6a3Cre mice
is localized to DA neurons, we crossed these mice with
Rosa26YFP reporter mice (Srinivas et al., 2001). Double immuno-
fluorescence labeling for yellow fluorescent protein (YFP) and
tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine
synthesis, revealed a high level of coexpression in the midbrain,
but not in the overlying cortex or hippocampus (Figures 1B and
1C). In addition, we detected YFP in other cells known to express
TH and DAT, such as the hypothalamus and olfactory bulb (data
not shown), similar to that previously described (Coulter et al.,
1996; Zhuang et al., 2005; Turiault et al., 2007). The extent of
Grin1 gene inactivation in KOmicewas examined by immunohis-
tochemistry using antibodies against NR1. KOmice displayed no
observable expression of NR1 in TH-expressing midbrain DA
neurons compared to controls; however, NR1 expression in
non-DA cells in the midbrain was normal (Figure 1D).
To confirm a lack of functional NMDARs, whole-cell, voltage-
clamp recordings from DA and non-DA neurons were obtained
from brain slices through the VTA of KO and control mice.
DA neurons were identified by the presence of hyperpolariza-
tion-activated potassium currents (Ih) (Figure 2A) asFigure 1. Generation and Histological Characterization of KO and
Control Mice
(A) Schematic of Slc6a3 and Grin1 alleles in control and KO mice. Wild-type
Slc6a3 allele (1), Slc6a3Cre allele (2), Grin1lox allele (3), and Grin1D allele (4).
(B) Low-power (2.53) image of immunofluoresence staining for YFP, TH, and
Hoechst nuclear stain in the midbrain of Rosa26YFP reporter mice.
(C) High-power (203) image of double immunofluoresence staining of VTA DA
neurons for TH and YFP.
(D) High-power (203) image of double immunofluoresence staining of VTA DA
neurons for TH and NR1. NR1 expression was undetectable in TH-positive
(arrows), but not TH-negative (arrow heads) neurons in the VTA of KO mice.Neuron 59, 486–496, August 14, 2008 ª2008 Elsevier Inc. 487
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Schilstrom et al., 2006; Ungless et al., 2001). There was no
NMDAR component of the excitatory postsynaptic current
(EPSC) in DA neurons from KO mice (Figure 2B); however,
NMDAR-mediated EPSCs were intact in non-DA neurons of
the VTA of KO mice (Figure 2B).
NMDAR activation is thought to be critical for the induction of
LTP in DA neurons (Borgland et al., 2004; Saal et al., 2003; Schil-
strom et al., 2006; Ungless et al., 2001). We monitored evoked
excitatory, postsynaptic potential (EPSP) amplitudes in DA neu-
rons from VTA slices following high-frequency afferent stimula-
tion using a spike-timing protocol of induction (Liu et al., 2005).
As predicted, we observed robust LTP in DA neurons from
control, but not KO mice (Figures 2C and 2D).
Inactivation of NMDARs and In Vivo Cocaine Exposure
Evoke Similar Changes in Synaptic AMPAR Currents
Many drugs of abuse produce an LTP of AMPAR currents in DA
neurons that is blocked by NMDAR antagonists (Borgland et al.,
2004; Liu et al., 2005; Saal et al., 2003; Ungless et al., 2001). To
determine if NMDAR activation in DA neurons is necessary for
Figure 2. Inactivation of Functional NMDAR in DA Neurons
(A) Representative traces of Ih currents used to identify DA (left) and non-DA
neurons (right).
(B) Representative traces of NMDAR and AMPAR EPSCs from DA and non-DA
neurons recorded from VTA slices of control and KO mice.
(C) LTP evoked by high-frequency afferent stimulation was not induced in DA
neurons from KO mice.
(D) Histogram representing the magnitude of percent increase in EPSP ampli-
tude 25 min after induction (*p < 0.01, Student’s t test). Data are from VTA
slices from control (n = 7) and KO (n = 6) mice and represent means ± SEM.488 Neuron 59, 486–496, August 14, 2008 ª2008 Elsevier Inc.cocaine-evoked LTP of synaptic AMPAR currents, wemonitored
spontaneous miniature excitatory postsynaptic currents
(mEPSCs) in drug-naive and cocaine-treated mice (Figure 3A)
as previously described (Ungless et al., 2001). As predicted,
a single cocaine exposure increased mEPSC amplitude and
frequency in control mice (Figures 3B and 3C). Unexpectedly,
drug-naive KO mice also showed a significant increase in
mEPSC amplitude (16.3 ± 1.3 pA versus 10.8 ± 0.8 pA,
p < 0.01 student’s t test) and frequency (3.2 ± 0.3 Hz versus
1.6 ± 0.2 Hz, p < 0.01 student’s t test) compared to drug-naive
controls (Figures 3B and 3C). These changes were similar to
the increases associated with a single cocaine exposure (Figures
3B and 3C).
Cocaine increases postsynaptic AMPAR currents in DA
neurons without affecting presynaptic transmitter release, as
monitored by the paired-pulse ratio between two electrical stim-
uli applied at an interval of 50 ms (Ungless et al., 2001). Similarly,
we did not observe a significant difference in paired-pulse ratio in
DA neurons from control and KOmice (0.861 ± 0.056, n = 19, ver-
sus 0.941 ± 0.053, n = 25, respectively). To confirm that changes
in mEPSC amplitude and frequency observed in KO mice is due
to increased postsynaptic AMPAR currents similar to that
evoked by cocaine, we monitored AMPA-evoked EPSCs using
whole-cell voltage clamp in VTA slices from drug-naive and co-
caine-treated control and KOmice as described (Borgland et al.,
2004; Liu et al., 2005; Ungless et al., 2001). Consistent with our
data from mEPSCs, AMPA-evoked currents from KO mice
were significantly increased compared to controls (peak change
in current, 282 ± 41 pA versus 110 ± 24 pA, p < 0.01, Student’s
t test) and was not different than cocaine-treated mice (Figures
3D and 3E). These findings were confirmed by monitoring the in-
put-output relationship at various stimulus intensities. AMPAR
EPSCs were significantly larger at each stimulus intensity tested
(Figure 3F).
Because the DA transporter gene is expressed by embryonic
day 14 (Fujita et al., 1993), it is possible that early developmental
inactivation of NMDAR signaling engages compensatory
mechanisms resulting in increased synaptic AMPAR currents
(Turrigiano and Nelson, 2004). To determine whether increased
synaptic AMPAR are restricted to early developmental inactiva-
tion of NMDAR, we injected an adenoassociated virus (AAV)
expressing a Cre-GFP fusion protein directly into the VTA of
3-week-old mice, a time after which DA dependence has devel-
oped (Zhou and Palmiter, 1995). Synaptic AMPAR currents were
monitored 3–5 days following viral injection. AAV-Cre-GFP trans-
duction of DA neurons significantly decreased NMDAR EPSCs,
increasing overall AMPAR/NMDAR ratios compared to neigh-
boring GFP-negative DA neurons (2.71 ± 0.36 versus 1.24 ±
0.12, p < 0.01). Similar to KO mice, AMPAR mEPSCs amplitude
and frequency were significantly increased in GFP-positive DA
neurons compared to GFP-negative DA neurons (Figures 3G
and 3H). These findings indicate that NMDAR inactivation
-induced increases in synaptic AMPAR currents are not
restricted to early development.
To determine whether genetic NMDAR inactivation also alters
inhibitory synaptic transmission,wemeasured spontaneousmin-
iature IPSCs (mIPSC) in DA neurons from control and KOmice as
described (Liu et al., 2005). mIPSC amplitude (Figure 3I) and
Neuron
Dopamine Neuron Plasticity and Addictive BehaviorFigure 3. Cocaine and NMDAR Inactivation
Increase Synaptic AMPAR Currents in VTA
DA Neurons
(A) Average AMPAR miniature EPSCs (mEPSCs)
from DA neurons of drug-naive control and KO
mice 24 hr after a single cocaine (20 mg/kg) injec-
tion (mEPSCs traces are the average of 60 con-
secutive events).
(B) Histogram of average mEPSC amplitude
(**p < 0.01 compared to control, Student’s t
test).
(C) Histogram of average mEPSC frequency
(**p < 0.01 compared to control, Student’s t
test). Data collected from VTA slices from naive
control, n = 6; naive KO, n = 8; cocaine-treated
control, n = 6; and cocaine-treated KO, n = 4
(B and C).
(D) Average AMPA-evoked (2.5 mMAMPA in 50 mM
cyclothiazide, ctz) EPSCs in DA neurons from
drug-naive control and KOmice 24 hr after a single
cocaine (20 mg/kg) injection.
(E) Histogram of average change in AMPA-evoked
currents 150 s after AMPA application (p < 0.01
compared to control, Student’s t test). Data col-
lected from VTA slices from naive control, n = 7;
naive KO, n = 7; cocaine-treated control, n = 6;
and cocaine-treated KO, n = 4 (D and E).
(F) Input-output curves from stimulus-evoked
AMPAR EPSCs expressed as a fixed increase
over threshold (*p < 0.05, **p < 0.01 compare to
control, Student’s t test). Data collected from VTA slices from naive control, n = 6; naive KO, n = 7; cocaine-treated control, n = 6; and cocaine-treated KO, n = 4.
(G) Histogram of average mEPSC amplitude from AAV-Cre-GFP transduced and control DA neurons.
(H) Histogram of average mIPSC frequency. Data collected from GFP-negative, n = 9, and GFP-positive, n = 8 cells (G and H).
(I) Histogram of average mIPSC amplitude.
(J) Histogram of average mIPSC frequency. Data collected from VTA slices from control, n = 8, and KO, n = 9 (I and J).
Data expressed as means ± SEM.frequency (Figure 3J) were not different between the two
groups, indicating that chronic NMDAR inactivation selectively
modulates excitatory, but not inhibitory synaptic transmission.
Altered Glutamate Signaling in DA Neurons of KO Mice
DoesNot Affect Locomotor-Stimulating Effects of Drugs
Increased AMPAR signaling in DA neurons is correlated with
elevated DA release and heightened responses to the psycho-
motor-stimulating effects of drugs of abuse (Carlezon et al.,
1997; Zhang et al., 1997); thus, chronic absence of NMDARs
and consequent enhancement of AMPAR currents might alter
the excitability of these cells resulting in enhanced locomotor ac-
tivity. To determine if KOmice have heightened locomotor activ-
ity in general, we monitored their exploratory behavior during
a 90 min exposure to novel activity chambers. The time course
of habituation to novelty (Figure 4A) and cumulative locomotor
activity (Figure 4G) did not differ between the two groups. Loco-
motor activity during a single day-night cycle was also moni-
tored. Both control and KO mice were relatively inactive during
the light phase (day) and demonstrated increased activity shortly
after dark phase (night) onset that persisted for approximately
12 hr (Figure 4B).
Psychomotor-stimulating effects of drugs of abuse are
mediated by increasing synaptic DA levels in the NAc. Morphine
enhances DA release by decreasing inhibitory inputs onto DAneurons, cocaine blocks DA reuptake, and amphetamine purges
vesicular DA pools and blocks reuptake (Vanderschuren and
Kalivas, 2000). Cumulative locomotor responses to morphine
(25mg/kg), cocaine (20mg/kg), or amphetamine (2.5mg/kg) dur-
ing the 90 min after drug exposure did not differ between the two
groups (Figure 4G). In addition, the kinetics of drug-induced loco-
motor activity was similar in both groups ofmice (Figures 4C–4E).
To determine if response to DA signaling is altered in KOmice,
wemonitored locomotor activity in response to the D1/D5 recep-
tor agonist SKF81297 (7.5 mg/kg i.p.). We did not observe
a significant difference between KO and control mice (Figures
4F and 4G). Thus, loss of functional NMDAR in DA cells does
not significantly affect locomotor responses associated with ac-
tivation of DA signaling, suggesting that the increased AMPAR
currents in KOmice do not affect DA release, reuptake, or signal-
ing to postsynaptic cells.
The Initial Phase of Behavioral Sensitization to Cocaine
Does Not Require NMDAR Activation
NMDAR-dependent LTP of AMPAR currents following a single
cocaine injection is thought to underlie the acquisition of behav-
ioral sensitization. To determine if behavioral sensitization to
cocaine is dependent on NMDAR signaling in DA neurons, we
monitored locomotor activity in response to cocaine administra-
tion for 5 consecutive days in an activity chamber that wasNeuron 59, 486–496, August 14, 2008 ª2008 Elsevier Inc. 489
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(20 mg/kg) produced a significant increase in activity that did
not differ between control and KO mice (Figures 5A and 5B).
We also monitored locomotor activity in response to repeated
injections of 15mg/kg cocaine but did not observe robust behav-
ioral sensitization in either group of mice (data not shown).
Because our behavioral analysis was conducted on a genetic
background in which mice were heterozygous for Grin1 and
Slc6a3, it is possible that the results were skewed by an altered
baseline response to cocaine. To eliminate this possibility, we
monitored sensitization to 20 mg/kg cocaine in wild-type mice.
Locomotor activity in response to the first cocaine injection
and the level of sensitization was not different between wild-
type (Slc6a3+/+; Grin1+/+) and control (Slc6a3+lox; Grin1Cre/+)
mice (day1 ambulations, 297 ± 68 versus 245 ± 72; and day 5
ambulations, 894 ± 213 versus 835 ± 136, respectively).
Locomotor sensitization continues to increase after cocaine
administration stops (Heidbreder et al., 1996); thus,we alsomon-
itored locomotor response to cocaine (20 mg/kg) in control and
KOmice after 3 and21daysofwithdrawal. Locomotor responses
Figure 4. Novelty and Drug-Induced Loco-
motor Activity
(A) Locomotor response to novel environment
(control, n = 12, and KO, n = 13).
(B) Day-night locomotion (control, n = 9, and KO,
n = 7).
(C) Locomotor response to morphine (25 mg/kg)
(control, n = 7, and KO, n = 8).
(D) Locomotor response to amphetamine
(2.5 mg/kg) (control, n = 12, and KO, n = 13).
(E) Locomotor response to cocaine (20 mg/kg)
(control, n = 15, and KO, n = 12).
(F) Locomotor response to D1/D5 receptor agonist
SKF 81297 (7.5 mg/kg) (control, n = 7, and KO,
n = 8).
(G) Cumulative ambulations for 90 min following
exposure to a novel environment (NOV), cocaine
(COC, 20 mg/kg i.p.), amphetamine (AMP,
2.5 mg/kg i.p.), morphine (MOR, 25 mg/kg s.c.),
or D1/D5 receptor agonist SKF 81297 (SKF,
7.5 mg/kg i.p.).
Data are presented as mean ± SEM.
after 3 days of cocaine withdrawal were
not significantly different in the two
groups; however, after 21 days of with-
drawal there was a significant enhance-
ment of behavioral sensitization in control
mice that was not observed in KO mice
(Figures 5A and 5C; repeated-measures
ANOVA, F(7,175) = 3.93, p < 0.05).
Conditioned Behavioral Responses
to Cocaine Depend on Functional
NMDAR in DA Neurons
After drug sensitization, locomotor activ-
ity increases when a rodent is placed in
the conditioning chamber; this is thought
to reflect cue- (or environment-) induced
incentive motivation (Berridge and Robinson, 1998). To deter-
mine if functional NMDAR signaling in DA neurons is necessary
for this context-dependent anticipatory locomotor activity, we
monitored the initial locomotor responses of mice during the
daily habituation phase that preceded cocaine administration
in the sensitization experiment. The highest level of locomotor
activity occurred during the first 15 min of re-exposure to the
conditioning chamber (Figure 5D). Analysis of cumulative loco-
motor responses during the first 15min revealed significantly en-
hanced anticipatory locomotor responses on the fifth day of
training and after 3 or 21 days of cocaine withdrawal by control
but not by KO mice (Figure 5E; repeated-measures ANOVA:
F(6,150) = 3.88, p = 0.001).
To determine if CPP for cocaine is also attenuated in KO mice,
we used a balanced, unbiased CPP paradigm. Baseline prefer-
ence for the conditioning chambers was determined during a 20
min pretest; we did not observe a significant chamber preference
in either group (data not shown). The next day, control and KO
mice were given either cocaine (10 mg/kg or 20 mg/kg) or saline
in contextually distinct compartments of a three-compartment490 Neuron 59, 486–496, August 14, 2008 ª2008 Elsevier Inc.
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trol mice, but not KO mice, displayed a significant preference for
the drug-paired side at both 10mg/kg (Figure 6A; repeated-mea-
sures ANOVA, test day F(3,60) = 3.02, p = 0.036; post hoc analysis
control, all test days versus baseline p < 0.05; KO, p > 0.4, no sig-
nificant genotype3 day interaction was detected) and 20 mg/kg
(Figures 6C and 6E; repeated-measures ANOVA, day F(3,60) =
2.83, p = 0.045; post hoc analysis control, all test days versus
baseline p < 0.05; KO, p > 0.6, no significant genotype 3 day in-
teraction was detected). Locomotor responses to cocaine during
pairing sessionsdidnotdiffer between the twogroups (Figures6B
and 6D).
To examine whether KO mice can learn a context-dependent
association, we monitored conditioned place aversion (CPA) to
a noxious stimulus. Similar to cocaine CPP, mice were given
three pairing sessions of saline in one compartment and nalox-
one (100 mg/kg s.c.) in the other compartment. On intermittent
days, mice were tested for CPA. Both KO and control mice dem-
onstrated a statistically significant CPA to naloxone during the
third test session (Figure 6F).
Conditioned Behavioral Responses to Cocaine Depend
on Functional NMDAR in the VTA
To confirm that the deficits observed in contextual reward asso-
ciation are due to a disruption of mesolimbic DA neurons and not
Figure 5. Behavioral Sensitization to
Cocaine
(A) Cumulative 90 min locomotor response to
cocaine (20 mg/kg, i.p.) from control (n = 15) and
KO (n = 12) mice across days; DW, days with-
drawal (*p < 0.05 compared to control treatment
day 5 and KO 21 DW).
(B) Ambulations per 5 min bin in response to
cocaine on treatment days 1 and 5.
(C) Ambulations per 5 min bin in response to
cocaine after 21 days of withdrawal (21 DW).
(D) Locomotor activity per 5 min bin on treatment
days 1 and 5 during 90 min habituation to activity
chambers.
(E) Average anticipatory locomotor activity during
the first 15 min of the habituation phase (*p <
0.05 compared to treatment day 1).
Data are presented as means ± SEM.
other DAT-expressing cells, we injected
AAV-Cre-GFP directly into the VTA. Al-
though AAV-Cre-GFP viral transduction
is not restricted to DA neurons in the
VTA, it does provide anatomical specific-
ity. Two weeks following AAV-Cre-GFP
injections, mice were assessed for co-
caine CPP. Following completion of the
CPP paradigm, viral transduction of DA
neurons was determined by counting
the number of TH-positive cells in the
VTA that were colabeled with nuclear
GFP (Figure 7A). We did not observe
a significant effect of viral injection on
the overall number or health of TH-positive neurons (Figure 7A
and data not shown). Because CPP scores for mice with <50%
TH/GFP colabeling (average % TH/GFP, 19% ± 8.9%) were
not different than heterozygous control-injected mice, we com-
bined them into a single control group. Average CPP scores
across days revealed a significant difference between mice
with >50% GFP/TH colabeling (VTA KO, average % TH/GFP,
72% ± 5.3%) and controls (repeated-measures ANOVA, day
F(3,45) = 9.2496, p < 0.001; post hoc analysis controls, all test
days versus baseline p < 0.01; VTA KO, p > 0.2 all test days ver-
sus baseline; Figure 7B). Locomotor responses to cocaine did
not differ between groups (Figure 7C). VTA KO mice showed
elevated locomotor activity during baseline testing compared
to controls (7,102 ± 680 cm versus 10,537 ± 1,149 cm; p < 0.01,
Students t test); however, we did not detect differences on sub-
sequent test days (4460 ± 424 cm versus 6164 ± 916 cm, test 1;
5242 ± 610 cm versus 5132 ± 838 cm, test 2; 5211 ± 726 cm ver-
sus 5402 ± 701). These findings indicate that functional NMDARs
are necessary in the VTA for contextual reward association.
DISCUSSION
Selective genetic inactivation of NMDARs in DA neurons
increased synaptic AMPARcurrents, and themagnitude of the in-
crease was similar to that observed after a single cocaineNeuron 59, 486–496, August 14, 2008 ª2008 Elsevier Inc. 491
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unexpected because it had not been reported following genetic
inactivationofNMDAR inother cell types (Iwasato et al., 2000;Na-
kazawaetal., 2002;Tsienet al., 1996); however, since thesubmis-
sionof thismanuscript, twoother studieshave reported increased
synaptic AMPAR currents similar to those described here (Ultanir
et al., 2007; Adesnik et al., 2008). Increased synaptic AMPARcur-
rents following pharmacological blockade of NMDAR has been
suggested to be a process of synaptic scaling restricted to a crit-
ical period of synaptic development (Turrigiano and Nelson,
2004); however, the changes we observed in synaptic AMPAR
currents following viral-mediated NMDAR inactivation in DA neu-
rons from 3-week-old mice suggest that NMDAR-mediated syn-
aptic scaling of AMPAR is likely not restricted to a critical period
of DA neuron development because these changes were ob-
served after DA dependence develops in mice (Zhou and Pal-
miter, 1995; Kim et al., 2002).
Although the mechanism and function of synaptic scaling are
not fully resolved, increasing evidence indicates that activation
of NMDARs and its downstream targets play an important role
in establishing synaptic AMPAR levels beyond LTP and LTD
(Isaac et al., 2007). InhibitionNMDAR-mediatedminiature synap-
tic events during chronic action potential blockade leads to rapid
(<60min) changes in synapticAMPARs that is dependent on local
protein synthesis (Sutton et al., 2006). These changes are likely to
Figure 6. Conditioned Place Preference for
Cocaine
(A) Percent preference for cocaine-paired com-
partment during baseline (Base) and following 1,
2, or 3 pairings with cocaine at 10 mg/kg; n = 12
control mice and n = 10 KO mice (*p < 0.05
compared to baseline).
(B) Distance traveled during conditioning to
cocaine (10 mg/kg).
(C) Percent preference for cocaine-paired com-
partment during baseline (Base) and following 1,
2, or 3 pairings with cocaine at 20 mg/kg; n = 10
control mice and n = 12 KO mice (*p < 0.05
compared to baseline).
(D) Distance traveled during conditioning to
cocaine (20 mg/kg).
(E) Representative trace of locomotor activity dur-
ing baseline (Base) and test day 3 (test) in a control
and KO mouse.
(F) Percent preference for naloxone-paired com-
partment during baseline (Base) and following 1,
2, or 3 pairings with naloxone at 100 mg/kg (con-
trol n = 8 and KO n = 8) (*p < 0.05 compared to
baseline).
Data are presented as mean ± SEM.
involve downstream targets of NMDAR
activation, such as the immediate-early
gene Arc/Arg3.1. Consistent with this
idea, genetic inactivation of Arc/Arg3.1
leads to similar increases synaptic
AMPAR currents (Shepherd et al., 2006).
Ourobservations thatNMDAR inactiva-
tion leads to synaptic scaling of AMPAR
currents that resembled the LTP induced by cocaine treatment
allowed us to ask whether increased AMPAR currents in DA
neurons is sufficient to elicit a sensitized phenotype. If elevated
AMPAR currents observed in the KO mice increased the overall
excitability of DA neurons, then we predicted that basal activity
and locomotor responses to acute drug exposure would be
augmented. Instead, we found that acute responses to drugs of
abuse and behavioral sensitization to repeated cocaine were
normal. These findings indicate that increased AMPAR currents
are not sufficient to evoke a sensitized response and that the
induction of sensitization occurs without further increasing the
amplitude or frequency of AMPAR currents.
Our results related to drug sensitization appear to be at odds
with some, but not all, pharmacological and electrophysiological
studies implicating NMDAR-dependent LTP of AMPAR currents
in DA neurons for the induction of behavioral sensitization. These
differences may not be mutually exclusive. Repeated intra-VTA
infusion of an NMDAR agonist does not evoke a sensitized re-
sponse to a subsequent systemic cocaine injection (Schenk
and Partridge, 1997); however, repeated intra-VTA infusion of
an NMDAR antagonist blocks the induction of behavioral sensiti-
zation (Kalivas and Alesdatter, 1993; Vezina and Queen, 2000).
These findings suggest that NMDAR-dependent LTP of AMPAR
currents following acute drug exposure are necessary for the in-
duction of behavioral sensitization but are not sufficient to evoke492 Neuron 59, 486–496, August 14, 2008 ª2008 Elsevier Inc.
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sure to cocaine increases the magnitude of AMPAR LTP in DA
neurons that directly correlates to the acute increase of locomo-
tor activity; however, after repeated exposure to cocaine, the
correlation between synaptic strength and sensitization is lost
(Borgland et al., 2004). Transient LTP of AMPAR currents may
be necessary to initiate long-term changes in DA neurons that
are critical for sensitization to be expressed. Numerous changes
in DA neurons following cocaine exposure have been linked to
sensitization involving activation of neurotrophin signal transduc-
tion cascades (Berhow et al., 1995, 1996; Messer et al., 2000),
Figure 7. Conditioned Place Preference for Cocaine Following
NMDAR Inactivation in the VTA
(A) Bilateral distribution of GFP-positive cells in the VTA labeled with TH immu-
nofluoresence from a mouse with >50% colabeling (top) and <50% colabeling
(bottom).
(B) Average percent preference score during baseline and across test days in
VTA KO (n = 8) and control (n = 9) mice.
(C) Distance traveled during 20 min cocaine-pairing sessions.
Data are presented as mean ± SEM.changes in gene expression regulated by cAMP response-ele-
ment binding protein (Olson et al., 2005),metabotropic glutamate
signaling (Chiamulera et al., 2001; Bellone and Luscher, 2006;
Mameli et al., 2007), andGABA singling (Liu et al., 2005). Amech-
anism in which NMDAR-dependent LTP of AMPAR currents is
necessary, but not sufficient for behavioral sensitization would
explain why increased AMPAR currents in these KO mice does
not evoke a sensitized response to acute drug exposure and
why sensitization develops normally. Nonetheless, our current
findings cannot rule out the possibility that NMDAR on other cells
in the VTA, such as GABA neurons, are critical for sensitization.
Infusion of NMDAR antagonists increases locomotor activity
that is blocked by aGABA agonist (Narayanan et al., 1996). In ad-
dition, we observed increased locomotor activity in response to
novelty when NMDARs were indiscriminately inactivated in the
VTA that was not observedwhenNMDARswere selectively inac-
tivated in DA neurons, suggesting that NMDAR signaling in non-
DA neurons may be important for regulating locomotor activity.
Behavioral sensitization after cocainewithdrawal is impaired in
KOmice. This is consistentwith the observation thatNR1 expres-
sion increases following chronic cocaine administration (Fitzger-
aldetal., 1996) and followingprolongedcocainewithdrawal (Loftis
and Janowsky, 2000). In addition, analysis of human cocaine-
overdose victims revealed significantly increased NR1 mRNA
levels in the VTA (Tang et al., 2003). These delayed increases in
NR1 expression may account for the increase in behavioral sen-
sitization that occurs during withdrawal. Prolonged drug absti-
nence increases the probability of cue-induced drug craving in
humans and rats (Gawin and Kleber, 1986; Grimm et al., 2001),
suggesting that changes in NMDAR signaling in VTA DA neurons
may be a critical molecular substrate for the enhanced drug crav-
ing that escalates during withdrawal (Grimm et al., 2001).
The conditioned-locomotor response to cocaine-testing envi-
ronment (without cocaine administration) and the CPP for the
chamber where cocaine was administered are thought to require
learning to associate the hedonistic effect of the drug with the
environment in which it was experienced. Thus, the lack of antic-
ipatory locomotor activity and CPP for the environment in which
cocaine was administered to KO mice suggests that NMDAR in
DA neurons plays a critical role in contextual reward association.
It is possible that a lack of NMDAR in DA neurons might impair
burst firing by these cells (Overton and Clark, 1997). Bursts of
DA are thought to imprint salient information in forebrain regions
(Nicola et al., 2000); thus, a lack of cocaine CPP could be due to
compromised NMDAR-dependent burst firing by DA neurons.
In conclusion, the present study demonstrates that inactiva-
tion of NMDARs exclusively in DA neurons impairs contextual re-
ward association for cocaine and withdrawal-induced increases
in sensitization. Together, these findings support a role for
NMDAR-dependent modulation of DA neurons in cue-induced
relapse to drug seeking.
EXPERIMENTAL PROCEDURES
Animals
Generation of Slc6a3+/cre, Grin1D/lox Mice
Due topotential transient expression ofSlc6a-Cre in germcells, one copy of the
floxedGrin1 allele was inactivated (Grin1D/+) by a genetic cross withMox2-CreNeuron 59, 486–496, August 14, 2008 ª2008 Elsevier Inc. 493
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DNAof offspringwas used tomonitor ectopic recombination of theGrinlox allele
in non-DA cells by PCR. The Grinlox allele was genotyped by PCR primers (for-
ward, 50-AGATACAAGACCCTGACT; reverse, 50-AGATGGTTGTGTTGTGAG)
flanking the 50 loxP site. TheGrin1D allelewas genotyped using the sameGrinlox
forwardprimer anda reverse primer (50-CACTTGAGTAGCGCCAAGTGC) in the
Pgk promoter of the Pgk-Neomycin cassette.
Behavior
All animal protocols were approved by the University of Washington, and
University of California, San Francisco, Institutional Animal Care and Use
Committees.
Locomotor activity was measured as consecutive beam breaks in activity
chambers (San Diego Instruments, San Diego, CA). Prior to drug administra-
tion, animals were habituated to saline injections for 2 consecutive days in lo-
comotor chamber; on the third day, animals were habituated for 90min prior to
drug injection.
CPP was measured as percent of time spent in cocaine-paired compart-
ments, activity was monitored with a video acquisition system (Canopus Me-
diaCruise, Tokyo, Japan), and data were analyzed using Ethovision software
(Noldus Information Technology, Leesburg, VA). Mice were paired using an
unbiased conditioning paradigm, such that an equal number of mice received
cocaine in the preferred and nonpreferred chamber (Heusner and Palmiter,
2005).
Viral Injections
AAV-Cre-GFP virus contains an open reading frame encoding Cre-EGFP fu-
sion protein with a myc tag and nuclear localization signal at the N terminus.
It is driven by the cytomegalovirus-chicken beta-actin (CBA) promoter and is
followed by a woodchuck postregulatory element (WPRE) and bovine growth
hormone (bGH) polyadenylation sequence. It was prepared by transfection of
HEK cells with helper plasmids and a plasmid expressing the AAV1 coat pro-
tein. The virus was purified by iodixanol and Q column procedures and titered
at 1.23 1012 particles/ml. For viral injection experiments, mice were anesthe-
tized with ketamine 100 mg/kg, xylazine 20 mg/kg, and acepromazine 0.6 mg/
ml and injected with 0.5 ml AAV-Cre-GFP bilaterally into the VTA using stereo-
taxic coordinates (x = 0.5, y = 3.5, and z = 4.5; Paxinos and Franklin, 2001).
Mice were allowed recover for 2 weeks prior to behavioral testing. Slice elec-
trophysiology was performed 3 to 5 days after viral injections.
Immunohistochemistry
Proteins were detected with primary antibodies to tyrosine hydroxylase
(monoclonal antibody 1:1000, Chemicon, Temecula, CA), NR1 (polyclonal an-
tibody 1:100; Chemicon, Temecula, CA), and YFP (polyclonal antibody 1:1000;
Molecular Probes, Eugene, OR). Primary antibodies were detected using CY2-
or CY3-conjugated, goat anti-mouse and goat anti-rabbit antibodies (1:200,
Jackson Immunolabs, West Grove, PA).
VTA Slice Preparations
VTA slices from young adult mice (p25 to p35) were prepared as previously de-
scribed (Ungless et al., 2001). In brief, mice were anesthetized with halothane
and killed. A block of tissue containing midbrain was sliced in the horizontal
plane (190 mm) in ice-cold low Ca2+ artificial cerebrospinal fluid (ACSF). Slices
were then transferred to a holding chamber containing ACSF, in mM, 126
NaCl, 1.6 KCl, 1.2 NaH2PO4, 1.2MgCl2, 2.5 CaCl2, 18 NaHCO3 and 11 glucose
and equilibriated at 31C–34C for at least 1 hr. All solutions were bubbled with
95% O2/5% CO2 and perfused over the slice at a rate of 2.5 ml/min.
Electrophysiology
Whole-cell recordings were performed using an Axopatch 1D amplifier (Axon
Instruments, Foster City, CA). For EPSCs recordings, electrodes (2–6 MU)
contained in mM: 120 cesium methansulfonic acid, 20 HEPES, 0.4 EGTA,
2.8 NaCl, 5 TEA-Cl, 2.5 MgATP, 0.25 MgGTP (pH 7.2–7.4). Picrotoxin (100 mM)
was added to the ACSF for recording, to block GABAA receptor-mediated
IPSCs.
NMDAR or AMPAR traces were constructed by averaging 15 EPSCs elicited
at +40 mV or at 70 mV. NMDAR responses were calculated by subtracting
the average response in the presence of 50 mM D-APV (AMPAR only) from494 Neuron 59, 486–496, August 14, 2008 ª2008 Elsevier Inc.that recorded in its absence. AMPA mEPSCs were collected using Clampex
(Axon Instruments) from cells voltage-clamped at 70 mV in the presence of
lidocaine (500 mM) and of D-APV (50 mM) (120 sweeps for each cell, 1 s per
sweep) and analyzed using Mini Analysis program (Synaptosoft, Decatur,
GA). Detection limit was set to include only events >7 pA, <1 ms rise time,
and <3 ms decay time.
For mIPSCs recordings, electrodes (2–6 MU) contained in mM: KCl 128,
NaCl 20, MgCl2 1, EGTA 1, CaCl2 0.3, Mg-ATP 2, GTP 0.25, buffered with
HEPES 10 (pH 7.2–7.4). Neurons were voltage-clamped at 70 mV. D-APV
(50 mM) and CNQX (100 mM) were added to the ACSF for recording to block
NMDAR- and AMPAR-mediated synaptic currents and lidocaine (500 mM), to
abolish action potential-driven IPSCs. mIPSCs were measured as previously
described (Bonci and Williams, 1997). For evoked excitatory postsynaptic po-
tentials (EPSPs), recordings electrodes (2–6 MU) contained 0.95% KOH (v/v),
0.76% methanesulfonic acid (v/v), 0.18% hydrochloric acid (v/v), 20 mM
HEPES, 0.2 mM EGTA, 2.8 mM NaCl, 2.5 mg/ml MgATP, and 0.25 mg/ml
GTP (pH 7.2–7.4). Neurons were current-clamped at70 mV, and LTP was in-
duced by using a spike-timing protocol as previously described (Liu et al.,
2005). Twenty bursts of EPSP spike pairs were delivered, with each burst con-
sisting of five paired stimuli delivered at 10 Hz (interburst interval of 5 s). The
postsynaptic spikes were evoked 5 ms after the onset of EPSPs by injecting
depolarizing current pulses (1–2 nA, 3 ms). The magnitude of LTP was com-
puted by averaging 30 consecutive EPSPs 5 min before and 25 min after the
end of the induction protocol.
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